Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 1.21, up from a previous target of HKD 0.75 [5][7]. Core Insights - The company reported a revenue of HKD 4.947 billion for FY26H1, representing a year-on-year increase of 33%, primarily driven by strong growth in IP derivatives, particularly from Aliyu [1]. - The net profit attributable to the parent company reached HKD 520 million, a 54% increase year-on-year, attributed to the excellent performance of Aliyu and a reduction in investment losses [1]. - Adjusted EBITA was HKD 550 million, a decrease of 14%, but when excluding a one-time financial asset impairment reversal of HKD 160 million from the previous year, the adjusted EBITA showed a 14% increase [1]. Summary by Sections IP Derivative Business - The IP derivative business generated revenue of HKD 1.16 billion, a significant year-on-year increase of 105.31%. The segment's performance was impacted by a one-time loss due to the shutdown of Jinli Naju, but the IP licensing business saw rapid growth, benefiting from collaborations with various IP brands [2]. Ticketing and Live Entertainment - Revenue from the company's performance content and technology business was HKD 1.339 billion, up 14.54% year-on-year. The growth was driven by ticket sales, although the pace was moderated by limited supply of performance content and venue resources [3]. Film and Series Production - Revenue from film-related businesses declined to HKD 1.064 billion, down 15.22% year-on-year. However, the series production business saw a remarkable increase of 693.44%, with revenue reaching HKD 484 million, driven by investments in high-quality content [4]. Profit Forecast and Valuation - The profit forecast has been revised upwards, with expected net profits for FY26-FY28 projected at HKD 915 million, HKD 1.16 billion, and HKD 1.374 billion, respectively. The target valuation for FY26 is set at 36 times PE, reflecting the ongoing high growth in the derivative business [5].